During the past decade, Synexus Polska Sp. z o.o. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus Polska Sp. z o.o." #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored and "Phathom Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Synexus Polska Sp. z o.o." are "Crohn's Disease" (2 trials), "COVID-19 Prevention" (1 trials), "Crohn Disease" (1 trials), "Depressive Disorder, Major" (1 trials) and "Erosive Esophagitis" (1 trials). Many other conditions were trialed in "Synexus Polska Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Synexus Polska Sp. z o.o." are "Drug" (11 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials), "Guselkumab Dose 3" (2 trials) and "Lansoprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Polska Sp. z o.o." are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus Polska Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Synexus Polska Sp. z o.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Polska Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".